drugset / Trial / NCT03767036

Administration of Tramadol and Ketorolac Separately and Simultaneously to Assess a Potential Pharmacokinetic Interaction

NCT03767036

RandomizedCrossoverOpen-labelTreatment

Summary

Tramadol (Tradol) and ketorolac (Dolac) are marketed products to treat acute pain. This study was performed to determine if both medications can be given to a patient simultaneously without a change of the products' bioavailability.

Timeline

Start
2017-06-05
Primary completion
2017-06-28
Completion
2017-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified 10 mg Oral
Subject Tramadol Other / unclassified 25 mg Oral

Indications

No indication recorded.